Literature DB >> 15644183

Analysis of T-cell development by using short interfering RNA to knock down protein expression.

Gabriela Hernández-Hoyos1, José Alberola-Ila.   

Abstract

We have applied RNA interference (RNAi) technology to the analysis of genes involved in T-cell development, combining a reaggregate fetal thymic organ culture (rFTOC) system with retroviral delivery of short interfering RNA (siRNA) hairpins. The process involves the isolation of murine fetal liver or fetal thymocytes, infection with retroviral particles carrying the construct of interest, followed by reaggregation of the transduced precursors with fetal thymic stroma into lobes. Subsequently, individual lobes are harvested and analyzed for development at various time points. These reaggregate cultures recapitulate most features of T-cell development in vivo, including pre-TCR selection and expansion, positive selection of CD4 and CD8 T cells, and negative selection. In our hands, the combination of retroviral delivery of RNAi and rFTOCs is a quick alternative to conventional knockouts for the analysis of gene function during T-cell development. This chapter describes the methods we have developed to knock down gene expression in T-cell precursors, using retroviral delivery of siRNA hairpins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644183     DOI: 10.1016/S0076-6879(04)92012-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  11 in total

1.  Retroviral Transduction of T Cells and T Cell Precursors.

Authors:  Amie Simmons; José Alberola-Ila
Journal:  Methods Mol Biol       Date:  2016

2.  siRNA as a tool for investigating organogenesis: The pitfalls and the promises.

Authors:  Wen-Chin Lee; Rachel Berry; Peter Hohenstein; Jamie Davies
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

3.  Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets.

Authors:  Taishan Hu; Hongcheng Wang; Amie Simmons; Sandra Bajaña; Ying Zhao; Susan Kovats; Xiao-Hong Sun; Jose Alberola-Ila
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

4.  Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.

Authors:  Marissa Morales Del Real; Ellen V Rothenberg
Journal:  Development       Date:  2013-03       Impact factor: 6.868

5.  GATA-3 dose-dependent checkpoints in early T cell commitment.

Authors:  Deirdre D Scripture-Adams; Sagar S Damle; Long Li; Koorosh J Elihu; Shuyang Qin; Alexandra M Arias; Robert R Butler; Ameya Champhekar; Jingli A Zhang; Ellen V Rothenberg
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

6.  Regulation of GATA-3 expression during CD4 lineage differentiation.

Authors:  Idoia Gimferrer; Taishan Hu; Amie Simmons; Chi Wang; Abdallah Souabni; Meinrad Busslinger; Timothy P Bender; Gabriela Hernandez-Hoyos; José Alberola-Ila
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

7.  Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.

Authors:  Erica J Reschly; Christina Spaulding; Tomas Vilimas; W Vallen Graham; Rachel L Brumbaugh; Iannis Aifantis; Warren S Pear; Barbara L Kee
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

8.  The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.

Authors:  Taishan Hu; Amie Simmons; Joan Yuan; Timothy P Bender; Jose Alberola-Ila
Journal:  Nat Immunol       Date:  2010-04-11       Impact factor: 25.606

9.  The Ras/MAPK pathway is required for generation of iNKT cells.

Authors:  Taishan Hu; Idoia Gimferrer; Amie Simmons; David Wiest; José Alberola-Ila
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

10.  Construction of siRNA/miRNA expression vectors based on a one-step PCR process.

Authors:  Jun Xu; Jie Qiong Zeng; Gang Wan; Gui Bin Hu; Hong Yan; Li Xin Ma
Journal:  BMC Biotechnol       Date:  2009-06-02       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.